| 1 | scientific invention journals elibrary | | | | | | | 2 | 0.72% |
| 2 | skip to main content | | | | | | | 1 | 0.36% |
| 3 | u saifa ashiba ashik | | | | | | | 1 | 0.36% |
| 4 | 479485 pdf utilization of | | | | | | | 1 | 0.36% |
| 5 | contraception among women of | | | | | | | 1 | 0.36% |
| 6 | among women of reproductive | | | | | | | 1 | 0.36% |
| 7 | women of reproductive age | | | | | | | 1 | 0.36% |
| 8 | of reproductive age in | | | | | | | 1 | 0.36% |
| 9 | reproductive age in ajman | | | | | | | 1 | 0.36% |
| 10 | age in ajman uae | | | | | | | 1 | 0.36% |
| 11 | in ajman uae navana | | | | | | | 1 | 0.36% |
| 12 | hemanth musamat u saifa | | | | | | | 1 | 0.36% |
| 13 | musamat u saifa ashiba | | | | | | | 1 | 0.36% |
| 14 | saifa ashiba ashik mehrin | | | | | | | 1 | 0.36% |
| 15 | yannick ngoumou 479485 pdf | | | | | | | 1 | 0.36% |
| 16 | ashiba ashik mehrin sherif | | | | | | | 1 | 0.36% |
| 17 | ashik mehrin sherif jayakumary | | | | | | | 1 | 0.36% |
| 18 | muttappallymyalil 486492 pdf comprehensive | | | | | | | 1 | 0.36% |
| 19 | 486492 pdf comprehensive analysis | | | | | | | 1 | 0.36% |
| 20 | pdf comprehensive analysis of | | | | | | | 1 | 0.36% |
| 21 | comprehensive analysis of pten | | | | | | | 1 | 0.36% |
| 22 | alterations in prostate cancer | | | | | | | 1 | 0.36% |
| 23 | in prostate cancer a | | | | | | | 1 | 0.36% |
| 24 | prostate cancer a cbioportal | | | | | | | 1 | 0.36% |
| 25 | cancer a cbioportal study | | | | | | | 1 | 0.36% |
| 26 | a cbioportal study chidozie | | | | | | | 1 | 0.36% |
| 27 | cbioportal study chidozie ogbonnaya | | | | | | | 1 | 0.36% |
| 28 | ngoumou 479485 pdf utilization | | | | | | | 1 | 0.36% |
| 29 | titus yannick ngoumou 479485 | | | | | | | 1 | 0.36% |
| 30 | alozie ononuju 503507 pdf | | | | | | | 1 | 0.36% |
| 31 | current issue articles published | | | | | | | 1 | 0.36% |
| 32 | present a centralized platform | | | | | | | 1 | 0.36% |
| 33 | that serves as a | | | | | | | 1 | 0.36% |
| 34 | serves as a gateway | | | | | | | 1 | 0.36% |
| 35 | as a gateway to | | | | | | | 1 | 0.36% |
| 36 | a gateway to the | | | | | | | 1 | 0.36% |
| 37 | gateway to the latest | | | | | | | 1 | 0.36% |
| 38 | to the latest breakthroughs | | | | | | | 1 | 0.36% |
| 39 | the latest breakthroughs across | | | | | | | 1 | 0.36% |
| 40 | latest breakthroughs across various | | | | | | | 1 | 0.36% |